Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,178,372
+$4,738,821 QoQ
Shares Held
1,241,816
+676.9% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $6,785,897,738 across 94 Medical Devices names. CATX ranks #49 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
14,505,201 | $1,489,248,984 | |
| 2 | BSX |
Boston Scientific Corp
|
18,891,624 | $1,185,449,403 | |
| 3 | SYK |
Stryker Corp
|
2,669,835 | $877,281,079 | |
| 4 | MDT |
Medtronic plc
|
5,600,590 | $485,291,119 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,082,050 | $406,970,562 | |
| 6 | PEN |
Penumbra Inc
|
720,575 | $236,615,212 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,266,138 | $232,483,701 | |
| 8 | DXCM |
Dexcom Inc
|
3,043,635 | $191,140,276 |
All Filings in CATX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,178,372 | 1,241,816 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $439,551 | 159,837 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $678,144 | 197,710 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $936,016 | 272,098 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $645,004 | 302,819 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,880,308 | 902,918 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $5,989,917 | 448,683 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||